期刊文献+

妊娠期伴乙型肝炎病毒感染对产妇及其新生儿结局的影响 被引量:1

下载PDF
导出
摘要 目的:分析妊娠期伴有乙型肝炎病毒(HBV)感染对产妇及其新生儿结局的影响。方法:选取2014年9月—2017年9月期间收治的妊娠期伴有HBV感染患者80例资料,根据资料中是否伴有肝功能损害将其分为肝功能正常组(n=47)和肝功能异常组(n=33),另选取同期于医院进行孕前产检的正常妊娠期者40例设为对照组;比较3组胎儿HBV感染情况、妊娠期并发症和产妇分娩结局的差异。结果:肝功能正常组产妇的新生儿HBV感染率为9.09%明显低于肝功能异常组为32.61%(χ2=6.041,P<0.05),产妇妊娠期并发症、新生儿畸形和早产的发生率均明显低于肝功能异常组(P<0.05);对照组孕妇妊娠期并发症、新生儿畸形和早产的发生率均明显低于肝功能正常组(P<0.05);3组产妇的剖宫产率、新生儿窒息的发生率经组间比较其差异无统计学意义(P>0.05)。结论:妊娠期伴有HBV感染严重影响了产妇及其新生儿结局,应重视妊娠期孕妇的产前检查,加强分娩期的监测,杜绝母-婴间HBV传播。
作者 徐沛演
出处 《抗感染药学》 2018年第8期1378-1380,共3页 Anti-infection Pharmacy
关键词 妊娠期 HBV 预后
  • 相关文献

参考文献5

二级参考文献151

  • 1Hassan El-Garem,Ayman Ammer,Hany Shehab,Olfat Shaker,Mohammed Anwer,Wafaa El-Akel,Heba Omar.Circulating micro RNA, mi R-122 and mi R-221 signature in Egyptian patients with chronic hepatitis C related hepatocellular carcinoma[J].World Journal of Hepatology,2014,6(11):818-824. 被引量:18
  • 2Bai F,Yano Y,Fukumoto T,et al.Quantification of pregenomic RNA and covalently closed circular DNA in hepatitis B virus-related hepatocellular carcinoma[J].Int J Hepatol,2013,2013:849290. 被引量:1
  • 3Kim HY,Choi JY,Park CH,et al.Outcome after discontinuing antiviral agents during pregnancy in women infected withhepatitis B virus[J].J Clin Virol,2013,56(4):299-305. 被引量:1
  • 4Pan CQ,Mi LJ,Bunchorntavakul C,et al.Tenofovir disoproxil fumarate for prevention of vertical transmission of hepatitis B virusinfection by highly viremic pregnant women:a case series[J].Dig Dis Sci,2012,57(9):2423-2429. 被引量:1
  • 5Yu Fu,Xufu Wei,Chengyong Tang,Jianping Li,Rui Liu,Ai Shen,Zhongjun Wu.Circulating microRNA?101 as a potential biomarker for hepatitis B virus?relatedhepatocellular carcinoma[J]. Oncology Letters . 2013 (6) 被引量:1
  • 6Verena K?berle,Bernd Kronenberger,Thomas Pleli,J?rg Trojan,Esther Imelmann,Jan Peveling-Oberhag,Martin-Walter Welker,Mohammed Elhendawy,Stefan Zeuzem,Albrecht Piiper,Oliver Waidmann.Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma[J]. European Journal of Cancer . 2013 被引量:2
  • 7Jin Hou,Li Lin,Weiping Zhou,Zhengxin Wang,Guoshan Ding,Qiongzhu Dong,Lunxiu Qin,Xiaobing Wu,Yuanyuan Zheng,Yun Yang,Wei Tian,Qian Zhang,Chunmei Wang,Qinghua Zhang,Shi-Mei Zhuang,Limin Zheng,Anmin Liang,Wenzhao Tao,Xuetao Cao.Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma[J]. Cancer Cell . 2011 (2) 被引量:3
  • 8Jipeng Li,Yiping Wang,Wanjun Yu,Jun Chen,Jianping Luo.Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance[J]. Biochemical and Biophysical Research Communications . 2011 (1) 被引量:1
  • 9Kevin Z. Qu,Ke Zhang,HaiRong Li,Nezam H. Afdhal,Maher Albitar.Circulating MicroRNAs as Biomarkers for Hepatocellular Carcinoma[J]. Journal of Clinical Gastroenterology . 2011 (4) 被引量:2
  • 10Christine Esau,Scott Davis,Susan F. Murray,Xing Xian Yu,Sanjay K. Pandey,Michael Pear,Lynnetta Watts,Sheri L. Booten,Mark Graham,Robert McKay,Amuthakannan Subramaniam,Stephanie Propp,Bridget A. Lollo,Susan Freier,C. Frank Bennett,Sanjay Bhanot,Brett P. Monia.miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting[J]. Cell Metabolism . 2006 (2) 被引量:4

共引文献43

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部